Fetal structural anomalies diagnosed during the first, second and third trimesters of pregnancy using ultrasonography
a retrospective cohort study
Keywords:
Ultrasonography, Prenatal, Prevalence, Fetal anomaliesAbstract
BACKGROUND: The prevalence of congenital abnormalities in general populations is approximately 3-5%. One of the most important applications of obstetric ultrasound is in detection of fetal structural defects. OBJECTIVE: To assess fetal structural anomalies diagnosed using ultrasound in the three trimesters of pregnancy. DESIGN AND SETTING: Retrospective cohort study at the Mário Palmério University Hospital of the Uni-versity of Uberaba (Universidade de Uberaba, UNIUBE), from March 2014 to December 2016. METHODS: Ultrasound data at gestational weeks 11-13 + 6, 20-24 and 32-36 were recorded to identify fetal anomalies in each trimester and in the postnatal period. The primary outcome measurements were sensitivity, specificity, positive predictive value and negative predictive value for detection of fetal anoma-lies and their prevalence. RESULTS: The prevalence of anomalies detected using ultrasound was 2.95% in the prenatal period and 7.24% in the postnatal period. The fetal anomalies most frequently diagnosed using ultrasound in the three trimesters were genitourinary tract anomalies, with a prevalence of 27.8%. Cardiac anomalies were diagnosed more often in the postnatal period, accounting for 51.0% of all cases. High specificity, negative predictive value and accuracy of ultrasound were observed in all three trimesters of pregnancy. CONCLUSION: Ultrasound is safe and has utility for detecting fetal anomalies that are associated with high rates of morbidity and mortality. However, the low sensitivity of ultrasound for detecting fetal anomalies in unselected populations limits its utility for providing reassurance to examiners and to pregnant women with normal results.
Downloads
References
Oakley GP Jr. Frequency of human congenital malformations. Clin Perinatol. 1986;13(3):545-54. PMID: 2945687; doi: 10.1016/S0095-5108(18)30809-1.
Donald I, Brown TG. Demonstration of tissue interfaces within the body by ultrasonic echo sounding. Br J Radiol. 1961;34:539-46. PMID: 13723680; doi: 10.1259/0007-1285-34-405-539.
Allan L. Fetal cardiac scanning today. Prenat Diagn. 2010;30(7):639-43. PMID: 20572107; doi: 10.1002/pd.2540.
Salomon LJ, Alfirevic Z, Berghella V, et al. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2011;37(1):116-26. PMID: 20842655; doi: 10.1002/uog.8831.
Borrell A, Robinson JN, Santolaya-Forgas J. Clinical value of the 11- to 13+6-week sonogram for detection of congenital malformations: a review. Am J Perinatol. 2011;28(2):117–24. PMID: 20700865; doi: 10.1055/s-0030-1263302.
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998;351(9125):343-6. PMID: 9717920. doi: 10.1016/s0140-6736(97)11280-6.
Pandya PP, Goldberg H, Walton B, et al. The implementation of first-trimester scanning at 10-13 weeks’ gestation and the measurement of fetal nuchal translucency thickness in two maternity units. Ultrasound Obstet Gynecol. 1995;5(1):20-5. PMID: 7850584; doi: 10.1046/j.1469-0705.1995.05010020.x.
Jones KL. Morphogenesis and dysmorphogenesis. In: Smith DW, editor. Smith’s Recognizable Patterns of Human Malformation. Philadelphia: WB Saunders; 1997. p. 695-705. ISBN 10: 0721661157; ISBN 13: 9780721661155.
Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11–13 weeks. Prenat Diagn 2011;31(1):90-102. PMID: 21210483; doi: 10.1002/ pd.2642.
Hildebrand E, Selbing A, Blomberg M. Comparison of first and second trimester ultrasound screening for fetal anomalies in the southeast region of Sweden. Acta Obstet Gynecol Scand. 2010;89(11):1412-9. PMID: 20955095; doi: 10.3109/00016349.2010.517307.
Luck CA. Value of routine ultrasound scanning at 19 weeks: a four year study of 8849 deliveries. BMJ. 1992;304(6840):1474-8. PMID: 1611369. doi: 10.1136/bmj.304.6840.1474.
Levi S, Schaaps JP, De Havay P, Coulon R, Defoort P. End result of routine ultrasound screening for congenital anomalies: the Belgian multicenter study 1984-92. Ultrasound Obstet Gynecol. 1995;5(6):366-71. PMID: 7552796; doi: 10.1046/j.1469-0705.1995.05060366.x.
Flood K, Malone FD. Screening for fetal abnormalities with ultrasound. Curr Opin Obstet Gynecol. 2008;20(2):139-45. PMID: 18388813; doi: 10.1097/GCO.0b013e3282f73253.
Saari-Kemppainen A, Karjalainen O, Ylöstalo P, Heinonen O. Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. Lancet. 1990;336(8712):387-91. PMID: 1974940; doi: 10.1016/0140-6736(90)91941-3.
Bucher HC, Schmidt JG. Does routine ultrasound scanning improve outcome in pregnancy? Meta-analysis of various outcome measures. BMJ. 1993;307(6895):13-7. PMID: 8343659; doi: 10.1136/ bmj.307.6895.13.
Crane JP, LeFevre ML, Winborn RC, et al. A randomised trial of prenatal ultrasonographic screening: impact on detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol. 1994;171(2):392-9. PMID: 8059817; doi: 10.1016/ S0002-9378(94)70040-0.
EUROCAT Guide 1.3 and reference documents. Instructions for the Registration and Surveillance of Congenital Anomalies. Available from: http://www.eurocat-network.eu/content/EUROCAT-Guide-1.3.pdf. Accessed in 2019 (Oct 5).
Salomon LJ, Alfirevic Z, Bilardo CM, et al. ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2013;41(1):102-13. PMID: 23280739; doi: 10.1002/uog.12342.
Organização Mundial da Saúde. Classificação Estatística Internacional de Doenças e Problemas Relacionados à Saúde: CID-10. 10th ed. São Paulo: Universidade de São Paulo http://www.datasus.gov.br/cid10/V2008/cid10.htm.
Parker SE, Mai CT, Canfield MA, et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008-16. PMID: 20878909; doi: 10.1002/bdra.20735.
Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol. 2010;686:349-64. PMID: 20824455; doi: 10.1007/978-90-481-9485-8_20.
Sallout B, Obedat N, Shakeel F, et al. Prevalence of major congenital anomalies at King Fahad Medical City in Saudi Arabia: a tertiary care centre-based study. Ann Saudi Med. 2015;35(5):343-51. PMID: 26506967; doi: 10.5144/0256-4947.2015.343.
Sheridan E, Wright J, Small N, et al. Risk factors for congenital anomaly in a multiethnic birth cohort: an analysis of the Born in Bradford study. Lancet. 2013;382(9901):1350-9. PMID: 23830354; doi: 10.1016/S0140-6736(13)61132-0.
Hamdan MA, Chedid F, Bekdache GN, et al. Perinatal outcome of congenital heart disease in a population with high consanguinity. J Perinat Med. 2015;43(6):735-40. PMID: 24728847; doi: 10.1515/jpm-2014-0019.
Leonardi-Bee J, Britton J, Venn A. Secondhand smoke and adverse fetal outcomes in nonsmoking pregnant women: a meta-analysis. Pediatrics. 2011;127(4):734-41. PMID: 21382949; doi: 10.1542/peds.2010-3041.
Vrijheid M, Martinez D, Manzanares S, et al. Ambient air pollution and risk of congenital anomalies: a systematic review and meta-analysis. Environ Health Perspect. 2011;119(5):598-606. PMID: 21131253; doi: 10.1289/ehp.1002946.
Hwang BF, Jaakkola JJ, Guo HR. Water disinfection by products and the risk of specific birth defects: a population-based cross-sectional study in Taiwan. Environ Health. 2008;7:23. PMID: 18518952; doi: 10.1186/1476-069X-7-23.
Ngo AD, Taylor R, Roberts CL. Paternal exposure to Agent Orange and spina bifida: a meta- analysis. Eur J Epidemiol. 2010;25(1):37-44. PMID: 19894129; doi: 10.1007/s10654-009-9401-4.
Rocha RS, Bezerra SC, Lima JW, Costa FS. Consumo de medicamentos, álcool e fumo na gestação e avaliação dos riscos teratogênicos [Consumption of medications, alcohol and smoking in pregnancy and assessment of teratogenic risks]. Rev Gaucha Enferm. 2013;34(2):37-45. PMID: 24015460; doi: 10.1590/S1983-14472013000200005.
Molina-Giraldo S, Alfonso-Ospina L, Parra-Meza C, et al. Prevalencia de malformaciones congénitas diagnosticadas por ultrasonido: tres años de experiencia en una unidad de medicina materno fetal universitaria [Prevalence in birth defects diagnosed by ultrasound: three years experience in university maternal fetal medicine unit]. Ginecol Obstet Mex. 2015;83(11):680-9. PMID: 27311166.
Chu C, Yan Y, Ren Y, Li X, Gui Y. Prenatal diagnosis of congenital heart diseases by fetal echocardiography in second trimester: a Chinese multicenter study. Acta Obstet Gynecol Scand. 2017;96(4):454-63. PMID: 28029179; doi: 10.1111/aogs.13085.
Zhang YF, Zeng XL, Zhao EF, Lu HW. Diagnostic Value of Fetal Echocardiography for Congenital Heart Disease: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2015;94(42):e1759. PMID: 26496297; doi: 10.1097/MD.0000000000001759.
Iliescu D, Tudorache S, Comanescu A, et al. Improved detection rate of structural abnormalities in the first trimester using an extended examination protocol. Ultrasound Obstet Gynecol. 2013;42(3):300-9. PMID: 23595897; doi: 10.1002/uog.12489.
Manegold G, Tercanli S, Struben H, Huang D, Kang A. Is a routine ultrasound in the third trimester justified? Additional fetal anomalies diagnosed after two previous unremarkable ultrasound examinations. Ultraschall Med. 2011;32(4):381-6. PMID: 21294069; doi: 10.1055/s-0029-1245799.
Skråstad RB, Eik-Nes SH, Sviggum O, et al. A randomized controlled trial of third-trimester routine ultrasound in a non-selected population. Acta Obstet Gynecol Scand. 2013;92(12):1353-60. PMID: 24032741; doi: 10.1111/aogs.12249.
Fugelseth D, Lindemann R, Sande HA, Refsum S, Nordshus T. Prenatal diagnosis of urinary tract anomalies. The value of two ultrasound examinations. Acta Obstet Gynecol Scand. 1994;73(4):290-3. PMID: 8160533. doi: 10.3109/00016349409015765.
Malinger G, Lerman-Sagie T, Watemberg N, et al. A normal second-trimester ultrasound does not exclude intracranial structural pathology. Ultrasound Obstet Gynecol. 2002;20(1):51-6. PMID: 12100418; doi: 10.1046/j.1469-0705.2002.00743.x.
Eurenius K, Axelsson O, Cnattingius S, Eriksson L, Norsted T. Second trimester ultrasound screening performed by midwives; sensitivity for detection of fetal anomalies. Acta Obstet Gynecol Scand. 1999;78(2):98-104. PMID: 10023870; doi: 10.1034/j.1600-0412.1999.780205.x.
Chitty LS. Ultrasound screening for fetal abnormalities. Prenat Diagn. 1995;15(13):1241-57. PMID: 8710765; doi: 10.1002/pd.1970151306.
Viellas EF, Domingues RM, Dias MA, et al. Assistência pré-natal no Brasil [Prenatal care in Brazil]. Cad Saúde Pública. 2014;30 Suppl 1:S1-15. PMID: 25167194; doi: 10.1590/0102-311X00126013.